image
BioAtla, Inc. BCAB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.336
-5.02 %
$ 19.6 M
Market Cap
-0.29
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
115.99%
EBIT Estimate
10.30%
Net Income Estimate
10.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets BioAtla, Inc.
image
BCAB has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart BCAB

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart BCAB

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart BCAB

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029